Register for OBR daily

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CVM $1.04 0.1500 +16.85%
AGEN $7.12 0.7500 +11.77%
ENZN $1.72 0.1800 +11.69%
GTXI $0.77 0.0590 +8.31%
OHRP $2.94 0.1200 +4.26%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

TLOG $4.31 -0.5100 -10.58%
SNTA $2.69 -0.2800 -9.43%
HTBX $6.89 -0.7100 -9.34%
APRI $1.61 -0.1300 -7.47%
ATRA $59.89 -4.1300 -6.45%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

MD Anderson Study Seeks Earlier Ovarian Cancer Detection

(MD Anderson) Apr 20, 2015 - Successful ovarian cancer treatment often relies on catching it early. A study at The University of Texas MD Anderson Cancer Center may help point to a new method for women at risk.
read press release 

MD Anderson Study Points to Potential New Lung Cancer Therapy

(MD Anderson) Apr 20, 2015 - New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer.
read press release 

Investigational Brain Cancer Vaccine Produces Strong Immunological Response

(RPCI) Apr 21, 2015 - A first-of-its kind cancer vaccine, SurVaxM, has demonstrated safety and tolerability in patients with recurrent or progressive malignant brain tumors, according to results of a phase I study conducted by Roswell Park Cancer Institute (RPCI) researchers.
read press release 

Worry May Drive Low-Risk Cancer Patients to Want Double Mastectomy

(Reuters Health) Apr 22, 2015 - Half of women with cancer in one breast - but no gene mutations that increase their risk - are interested in removing their healthy breast to avoid a second cancer there, a small survey finds.
read article 

Cold Plasma Used in World's First Clinical Surgical Procedure Performed to Selectively Kill Cancer Tumor Cells

(Yahoo! Finance) Apr 22, 2015 - A surgical team coordinated by the US Medical Innovations, LLC (USMI) family of companies, completed the world’s first clinical procedure using cold plasma for the selective killing of cancerous tissue at Baton Rouge General Medical Center in Baton Rouge, LA.
read article 

HPV Screening Alone May Miss Cervical Cancer

(Medscape Medical News) Apr 22, 2015 – Even though HPV screening has been approved as a standalone screening test, results from a large 'real-world' study show that it can miss cervical cancer.
read article (free registration required) 

'Personalised' Cancer Vaccine Moves a Step Closer

(The Independent [UK]) Apr 22, 2015 - A cancer vaccine that is tailor-made to work on individual patients has come a step closer following a study showing that a prototype injection causes the complete control of aggressive tumours in laboratory mice.
read article 

FDA Willing to Accept Different Endpoints When Assessing Lung Cancer Drugs

(RAPS/Regulatory Focus) Apr 22, 2015 - Companies will be permitted to use several types of clinical trial endpoints to show the efficacy of drugs intended to treat non-small cell lung cancer (NSCLC), the US Food and Drug Administration (FDA) confirmed in a new guidance document released this week.
read article 

Cancer Hospitals Participating in at Least Some Exchange Plan Networks

(Modern Healthcare) Apr 22, 2015 - Most specialized cancer hospitals say they participate in the narrow provider networks of some exchange health plans, but health insurers have not been shy keeping some cancer hospitals out, according to a new survey from consulting firm Avalere Health.
read article 

Teva Bid for Mylan Sparks Worries of Rising Generic Drug Prices

(Bloomberg) Apr 21, 2015 - A potential $40.1 billion generic-drug merger already has Brad Arthur bracing for a blow to his family-run pharmacy in Buffalo, New York.
read article 

Parsing The Latest Evidence That Aspirin And Coffee Keep Cancer Away

(Forbes) Apr 22, 2015 - Anyone looking for an excuse to get through the morning staff meeting by popping an aspirin and downing a lot of coffee has reason to cheer this week.
read article 

New Study Finds No Link Between Measles Vaccination, Autism

(Atlanta Journal Constitution [video]) Apr 22, 2015 - A new study of close to 100,000 children shows no link between the measles, mumps and rubella vaccine and an increased risk of autism.
read article 

FDA Takes New Look at Homeopathy

(Science Magazine/AAAS) Apr 21, 2015 - This week, officials at the U.S. Food and Drug Administration (FDA) took a 15-hour foray far outside the scientific mainstream. In a 2-day hearing, the agency invited public input on how it should regulate homeopathy—a traditional healing practice that has been called into question by numerous scientific studies.
read article 

FDA Kicks off Generic Drug User Fee Reauthorization Process

(RAPS/Regulatory Focus) Apr 21, 2015 - Regulators and generic pharmaceutical companies, start your engines. The race to the next reauthorization of the Generic Drug User Fee Act (GDUFA) has begun.
read article 

Maker of Controversial ALS Drug Hasn’t Filed Formal Application for FDA Approval

(Washington Post/To Your Health blog) Apr 21, 2015 - In recent months, Pasadena-based Genervon has galvanized many patients with ALS by repeatedly touting the results of 12-week, 12-person trial involving the company's drug, GM604.
read article (free registration required) 

FDA, CMS Form Interagency Task Force to Coordinate LDT Regulation

(GenomeWeb) Apr 21, 2015 - The US Food and Drug Administration and the Centers for Medicare & Medicaid Services have formed a task force to coordinate the two agencies' oversight of laboratory-developed tests (LDTs).
read article (free registration required) 

Medivir, Cancer Research Technology Team Up to Develop New Class of Cancer Drugs

(Drug Discovery & Development) Apr 13, 2015 - Medivir AB and Cancer Research Technology (CRT), Cancer Research UK’s commercialization and development arm, jointly announce a partnership to develop a new class of drugs that has shown promise for treating a range of different cancers, including pancreatic cancer.
read article 

Molecular Medicine Awards 3rd Annual Ross Prize to Dr. Lewis C. Cantley, Cancer Researcher at Weill Cornell Medical College and NY Presbyterian Hospital

(Feinstein Institute/North Shore-LIJ) Apr 21, 2015 - The Feinstein Institute for Medical Research today announced that Lewis C. Cantley, PhD, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College and NewYork-Presbyterian Hospital, will be the recipient of the third annual Ross Prize in Molecular Medicine.
read press release 

Actinium to Partner With Aplastic Anemia & MDS International Foundation Patient and Family Forums

(NASDAQ) Apr 22, 2015 - Actinium Pharmaceuticals, Inc. is partnering with the Aplastic Anemia & MDS International Foundation, a leading non-profit health organization, to present educational forums to patients and their families on bone marrow transplant, MDS, aplastic anemia and PNH.
read article 

Medocity to Demonstrate New Innovative Cancer Patient Care Platform at the 40th Annual Meeting of the Oncology Nursing Society in Orlando, FL, April 23-26, 2015

(Medocity) Apr 20, 2015 - Medocity, Inc. will demonstrate iCancerHealth, a unique mobile and web platform that bridges the care gap between the clinic and the patient’s home at the 40th Annual Meeting of the Oncology Nursing Society, April 23-26, 2015 in Orlando, FL.
read corporate press release 

The Mystery of Breast Cancer's Cause

(Discover Magazine blog/The Conversation) Apr 21, 2015 - For breast cancer, there is no smoking gun.
read article 

The Future of Cancer Treatment is (Almost) Here

(Wired) Apr 21, 2015 - Pharmaceutical companies—and oncologists who see patients every day—haven’t been able to fully harness the potential of sequencing.
read article 

Texas House Passes Bill To Quicken Access To Trial Drugs For Cancer Patients

(Texas Public Radio) Apr 22, 2015 - The Texas House overwhelmingly passed legislation designed to shorten the time when experimental medications can be given to terminally ill patients.
read article 

U.S. Cancer Institute, Software Firm Reach Deals in Cuba

(Reuters) Apr 21, 2015 - A U.S. cancer research center and a software company reached agreements with Cuban partners during a two-day trade mission to Cuba led by New York Governor Andrew Cuomo in the first trip of its kind since the rapprochement between Washington and Havana.
read article 

Cantrixil Receives Orphan Drug Designation from FDA

(MarketWatch) Apr 21, 2015 - US-Australian drug discovery company, Novogen, today announced that its subsidiary joint venture company with Yale University, CanTx, Inc, has today received notification from the FDA that its chemotherapy candidate drug, Cantrixil, has been granted Orphan Drug Designation for ovarian cancer.
read article